US FDA approves Ionis Pharma's therapy to treat rare brain disorder

The ​U.S. FDA on Thursday approved Ionis Pharmaceuticals' ‌therapy to treat a rare disease that affects the brain's white matter, making it the ​first treatment to get ​the nod for the genetic disorde...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。